USX:BCEL - Atreca Inc Atreca Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 10 Nov 2021
Add to Watchlist
   
Add Alert 


Yahoo Finance (Live Price)

USD 6.73    +0.290 (+4.50%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

21 Sep 2021


Loading...
Loading...
Loading...

General

CEO: Mr. John A. Orwin

IPO: 2019-06-20

Headquarters: US

Employees: 139

Homepage

Description

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.